DEERFIELD, Ill., May 16, 2024 PRNewswire -- Baxter International Inc. , a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive.Vantive logo.The Vantive mission, Extending Lives, Expanding Possibilities, will guide and inspire the proposed company, which will focus on vital organ therapies for acute and chronic kidney diseases and beyond.
The new Vantive branding will come into effect when the separation occurs, which is currently expected in the second half of 2024, via either a sale to a private equity investor or a spinoff into a publicly traded company.Until completion of the proposed separation, the Kidney Care business will continue to operate as Baxter. Read more about the proposed Kidney Care separation here.